Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives

SIMPLE SUMMARY: Despite recent advances in treatment, metastasized prostate carcinoma (PC) still has a poor prognosis. Immunotherapy has revolutionized the landscape of cancer therapy, but a breakthrough for PC is missing. The success of immunotherapy in cancers is mostly due to recent strategies to...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitmann, Jonas S., Pfluegler, Martin, Jung, Gundram, Salih, Helmut R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867165/
https://www.ncbi.nlm.nih.gov/pubmed/33535627
http://dx.doi.org/10.3390/cancers13030549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867165/
https://www.ncbi.nlm.nih.gov/pubmed/33535627
http://dx.doi.org/10.3390/cancers13030549

Ejemplares similares